GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, FLT3, GSK3B, HCAR2, KDR, MET, MMP9, NR1H4, PDE5A, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
9.07377 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, FLT3, GSK3B, HCAR2, KDR, MET, MMP9, NR1H4, PDE5A, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
9.07377 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DHFR, F10, FABP3, FABP4, FLT3, GSK3B, HCAR2, IDO1, IGF1R, KDR, MAOB, MET, MMP1, MMP2, MMP9, NR1H4, PDE5A, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, TNKS, TNKS2, XDH |
9.07377 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DHFR, F10, FABP3, FABP4, FLT3, GSK3B, HCAR2, HSD17B1, KDR, MAOB, MET, NR1H4, PPARA, PTGS2, SRC, THRA, THRB, TNKS, TNKS2, XDH |
9.07377 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, F10, FABP3, FLT3, GSK3B, HCAR2, IDO1, IGF1R, KDR, MAOB, MET, MMP1, MMP2, MMP9, NR1H4, PDE5A, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, TNKS, TNKS2, XDH |
8.52871 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, CA1, CA12, CA2, CA4, CA7, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, DHFR, FABP3, IDO1, NR1H4, PDE5A, PIM1, PPARA, PTGS2, XDH |
7.13165 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AXL, CSNK2A1, CYP1B1, F10, FLT3, GSK3B, KDR, MET, MMP9, NR1H4, PDE5A, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
6.51928 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, ADRA2A, AKR1B1, ALOX15, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, FABP4, FLT3, GSK3B, IDO1, IGF1R, KDR, MAOB, MMP2, MMP9, NR1H4, PPARA, PTGS2, RORC, SRC, TOP1 |
6.22143 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, FLT3, GSK3B, HCAR2, IGF1R, KDR, MET, MMP9, NR1H4, PDE5A, PTGS2, PTPN1, PTPRS, SRC, THRA, TNKS, TNKS2, XDH |
6.07063 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, DHFR, GSK3B, HSD17B1, IDO1, MAOB, PTGS2, XDH |
6.07063 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, CYP1A1, FABP3, FLT3, HCAR2, NR1H4, PPARA, PTGS2, RORC, SRC, THRA |
6.07063 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, FLT3, GSK3B, HCAR2, IDO1, IGF1R, KDR, MET, MMP9, NR1H4, PIM1, PPARA, PTGS2, PTPN1, SRC, THRA, XDH |
6.07063 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AXL, CSNK2A1, CYP1B1, F10, FABP4, FLT3, GSK3B, IDO1, KDR, MET, MMP2, MMP9, NR1H4, PDE5A, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
6.07063 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, FLT3, GSK3B, HCAR2, IGF1R, KDR, MET, MMP9, NR1H4, PDE5A, PTGS2, PTPN1, PTPRS, SRC, THRA, TNKS, TNKS2, XDH |
6.07063 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, ALOX15, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, FABP4, FLT3, GSK3B, IDO1, IGF1R, KDR, MAOB, MMP2, NR1H4, PPARA, PTGS2, RORC, SRC |
6.07063 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MAOB, MMP9, PTGS2, SRC |
6.06008 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, DHFR |
5.99567 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, HSD17B1, MET, NR1H4, PPARA, PTGS2 |
5.98566 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, FLT3, GSK3B, HCAR2, IDO1, IGF1R, KDR, MET, MMP9, NR1H4, PIM1, PTGS2, PTPN1, SRC, THRA, XDH |
5.97365 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, GSK3B, HCAR2, IGF1R, KDR, MAOB, MET, MMP9, NR1H4, PPARA, PTGS2, PTPN1, SRC, THRA |
5.9144 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, GSK3B, IDO1, IGF1R, KDR, MET, MMP9, NR1H4, PIM1, PPARA, PTGS2, PTPN1, SRC |
5.88275 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DHFR, FABP3, FABP4, GSK3B, HCAR2, IDO1, IGF1R, KDR, MAOB, MET, MMP9, NR1H4, PDE5A, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SRC, THRA, THRB, TNKS, TNKS2, XDH |
5.82481 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, DHFR, F10, FABP3, FABP4, FLT3, GSK3B, HSD17B1, IDO1, IGF1R, KDR, MAOB, MET, MMP1, MMP2, NR1H4, PDE5A, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SRC, THRA, THRB, TNKS, TNKS2, TOP1, XDH |
5.77348 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DHFR, F10, FABP4, FLT3, GSK3B, IDO1, IGF1R, KDR, MET, MMP2, MMP9, NR1H4, PDE5A, PPARA, PTGS2, PTPN1, PTPRS, SRC, THRA, TNKS, TNKS2, XDH |
5.72922 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DHFR, FABP3, FABP4, GSK3B, IDO1, IGF1R, KDR, MAOB, MET, MMP9, NR1H4, PDE5A, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SRC, THRA, THRB, TNKS, TNKS2, XDH |
5.72922 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, DHFR, F10, FABP3, FABP4, FLT3, GSK3B, HSD17B1, IDO1, IGF1R, KDR, MAOB, MET, MMP1, MMP2, MMP9, NR1H4, PDE5A, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SRC, THRA, THRB, TNKS, TNKS2, TOP1, XDH |
5.72922 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, GSK3B, IDO1, IGF1R, MAOB, MMP2, MMP9, NR1H4, PPARA, PTGS2, RORC, SRC |
5.70096 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, GSK3B, IDO1, IGF1R, KDR, MET, MMP9, NR1H4, PIM1, PTGS2, PTPN1, SRC |
5.64457 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.63355 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, FLT3, GSK3B, HCAR2, IDO1, IGF1R, KDR, MMP9, NR1H4, PIM1, PTGS2, PTPN1, SRC, THRA, XDH |
5.39096 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2 |
5.11698 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, CA2, CA7, HCAR2, KDR, NR1H4, PTGS2, SRC, TNKS, TNKS2 |
5.10792 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2 |
5.06622 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AXL, CYP1B1, F10, FLT3, KDR, MET, PDE5A, PTGS2, PTPN1, SRC, XDH |
5.03026 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, GSK3B, IDO1, IGF1R, KDR, MMP9, NR1H4, PIM1, PTGS2, PTPN1, SRC |
4.94483 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2 |
4.90344 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, AKR1B10, ALOX15, ALOX5, AXL, CYP19A1, CYP1A2, CYP1B1, F10, FABP4, IDO1, IGF1R, MET, MMP1, MMP2, MMP9, PDE5A, PIM1, PPARA, PTGS2, RORC, SRC, THRA, THRB, TNKS2, TOP1 |
4.90344 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP1B1, F10, FLT3, IGF1R, KDR, MET, MMP9, NR1H4, PDE5A, PTGS2, PTPN1, SRC, XDH |
4.8736 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, FABP3, FABP4, GSK3B, IDO1, MAOB, MMP1, MMP2, MMP9, PDE5A, SRC, XDH |
4.82764 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, AURKB, CSNK2A1, CYP1B1, FABP4, GSK3B, IGF1R, MET, MMP9, NR1H4, PIM1, PPARA, PTGS2, PTPN1, SRC, TNKS |
4.82764 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, AURKB, CDC25B, CSNK2A1, DHFR, FABP3, FLT3, GSK3B, IGF1R, KDR, MAOB, MET, MMP9, NR1H4, PDE5A, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, TNKS, TNKS2, XDH |
4.75775 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, AURKB, CDC25B, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MAOB, MET, MMP9, NR1H4, PDE5A, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, TNKS, TNKS2, XDH |
4.50234 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, AURKB, AXL, CDC25B, CSNK2A1, DHFR, FLT3, GSK3B, IGF1R, KDR, MET, PDE5A, PIM1, PTGS2, PTPN1, PTPRS, SRC, TNKS, TOP1, XDH |
4.37032 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, PIM1, SRC |
4.31979 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, CA2, CSNK2A1, CYP1A2, FABP3, FLT3, GSK3B, IGF1R, MAOB, MMP2, NR1H4, PPARA, PTGS2, SRC |
4.26821 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, CDC25B, CSNK2A1, CYP1B1, FABP3, FLT3, IDO1, IGF1R, KDR, MMP2, MMP9, PDE5A, PIM1, PTGS2, SRC, XDH |
4.25452 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, ADRA2A, CYP19A1, DHFR, FABP4, GSK3B, IDO1, IGF1R, MET, MMP2, NR1H4, PPARA, PTGS2, PTPN1, PTPRS, SRC, XDH |
4.25452 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, IDO1, NR1H4, PPARA, PTGS2 |
4.25452 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, AURKB, CDC25B, FABP3, FLT3, GSK3B, IGF1R, KDR, MAOB, MET, MMP9, NR1H4, PDE5A, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, TNKS, TNKS2, XDH |
4.25452 |
[BP] GO:0033993 |
response to lipid
|
AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, IDO1, MAOB, NR1H4, PTGS2, RORC, SRC |
4.23272 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, DAO, DHFR, FABP3, IDO1, NR1H4, PIM1, PPARA, PTGS2 |
4.21078 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, ALOX15, AXL, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, GSK3B, IGF1R, KDR, MMP2, MMP9, NR1H4, PTGS2, RORC, SRC |
4.19464 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP1B1, F10, FLT3, GSK3B, IGF1R, KDR, MET, MMP9, NR1H4, PDE5A, PTGS2, PTPN1, PTPRS, SRC, THRA, TNKS, TNKS2, XDH |
4.17412 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, ADRA2A, ADRA2C, ALOX15, AXL, CA2, CA7, CYP19A1, GSK3B, HCAR2, MAOB, MMP9, NR1H4, PPARA, PTGS2, PTPN1, SRC, THRA |
4.15758 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, AURKB, AXL, CDC25B, CSNK2A1, DHFR, FLT3, GSK3B, IGF1R, KDR, MET, PDE5A, PIM1, PTGS2, PTPN1, PTPRS, SRC, TNKS, TOP1, XDH |
4.14995 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGS2 |
4.14995 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HCAR2, HSD17B1, NR1H4 |
4.06015 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, HCAR2, NR1H4, PTGS2, TNKS, TNKS2 |
3.98711 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, ALOX15, AXL, CYP1A1, CYP1B1, FABP4, FLT3, GSK3B, IGF1R, KDR, MMP2, NR1H4, PTGS2, RORC, SRC |
3.97808 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, CYP19A1, CYP1A1, CYP1B1, DAO, DHFR, MAOB, NR1H4 |
3.9716 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2 |
3.95869 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CBR1, CYP1A1, CYP1A2, CYP1B1, DAO, DHFR, IDO1, MAOB |
3.95392 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, FABP3, NR1H4, PPARA |
3.94975 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1 |
3.9398 |
[BP] GO:0050994 |
None
|
ADORA1, ADRA2A, HCAR2, PPARA, THRA |
3.90215 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2 |
3.86013 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, DAO, DHFR, FABP3, IDO1, NR1H4, PIM1, PPARA, PTGS2 |
3.82209 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, CDC25B, FABP3, FLT3, KDR, MMP9, NR1H4, PDE5A, PTGS2, PTPN1, SRC, XDH |
3.82209 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, CDC25B, FABP3, FLT3, KDR, MMP9, NR1H4, PDE5A, PTGS2, PTPN1, SRC, XDH |
3.82209 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, NR1H4 |
3.76825 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, MET, PPARA, PTGS2 |
3.76362 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, DAO, DHFR, FABP3, IDO1, NR1H4, PIM1, PPARA, PTGS2 |
3.76362 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1, MAOB |
3.76362 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, AURKB, CDC25B, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MET, MMP9, NR1H4, PDE5A, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, TNKS, TNKS2, XDH |
3.76362 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, AURKB, AXL, CA2, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP4, FLT3, GSK3B, KDR, MAOB, MET, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPRS, RORC, SRC, THRA, THRB, TNKS2 |
3.73741 |
[BP] GO:0045932 |
None
|
ADORA1, ADRA2C, PDE5A, PTGS2 |
3.70783 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
NR1H4, PIM1, PPARA, RORC, SRC, THRA, THRB |
3.70783 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX15, AURKB, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, F10, FABP3, FABP4, FLT3, GSK3B, IDO1, IGF1R, KDR, MAOB, MMP2, MMP9, NR1H4, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, TOP1 |
3.70783 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, AURKB, AXL, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, DHFR, F10, FABP3, FABP4, FLT3, GSK3B, HSD17B1, IDO1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NR1H4, PDE5A, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SRC, THRA, THRB, TNKS, TNKS2, TOP1, XDH |
3.66408 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, AURKB, AXL, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, DHFR, F10, FABP3, FABP4, FLT3, GSK3B, HSD17B1, IDO1, IGF1R, KDR, MAOB, MET, MMP1, MMP2, MMP9, NR1H4, PDE5A, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SRC, THRA, THRB, TNKS, TNKS2, TOP1, XDH |
3.62025 |
[BP] GO:0050665 |
hydrogen peroxide biosynthetic process
|
CYP1A1, CYP1A2, MAOB |
3.54211 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, AXL, CYP1A1, CYP1B1, DHFR, FABP3, KDR, MAOB, PTGS2, SRC, TOP1 |
3.51016 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, F10, FLT3, GSK3B, IGF1R, KDR, MET, NR1H4, SRC, TNKS, TOP1 |
3.50889 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
AXL, CYP1A1, CYP1A2, IDO1, MAOB, NR1H4, PTGS2, SRC |
3.48578 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, NR1H4, PPARA, PTGS2, SRC |
3.45097 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, CDC25B, FABP3, FABP4, FLT3, IGF1R, KDR, MMP9, NR1H4, PDE5A, PPARA, PTGS2, PTPN1, SRC, XDH |
3.43673 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, DAO, DHFR, F10, FLT3, GSK3B, IDO1, IGF1R, KDR, MAOB, MET, MMP1, MMP2, MMP9, NR1H4, PDE5A, PIM1, PPARA, PTGS2, PTPN1, PTPRS, SRC, TNKS, TNKS2, TOP1, XDH |
3.41326 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA2A, ADRA2C, PDE5A, PTGS2, THRA, THRB |
3.40902 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, CDC25B, FABP3, FABP4, FLT3, IGF1R, KDR, MMP9, NR1H4, PDE5A, PPARA, PTGS2, PTPN1, SRC, XDH |
3.39808 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
NR1H4, PPARA, RORC, SRC, THRA, THRB |
3.32979 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA2A, ADRA2C, ALOX15, FLT3, KDR, PDE5A, PTPN1, SRC, XDH |
3.32739 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, CYP19A1, CYP1B1, F10, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
3.32739 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
AXL, CYP1A1, CYP1A2, IDO1, MAOB, NR1H4, PTGS2, SRC |
3.30538 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.26591 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.26591 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, CDC25B, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC, TNKS, TOP1 |
3.24592 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, ALOX15, AURKB, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP4, FLT3, GSK3B, IGF1R, KDR, MMP2, MMP9, NR1H4, PTGS2, PTPN1, RORC, SRC |
3.23021 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, CA2, CYP1B1, GSK3B, HCAR2, IDO1, KDR, MET, MMP9, NR1H4, PDE5A, PIM1, PTGS2, PTPRS, SRC, THRA, THRB, TNKS2, XDH |
3.21277 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, CA2, CSNK2A1, CYP1A2, FABP3, FLT3, MAOB, PPARA, PTGS2, SRC |
3.21277 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA2A, ADRA2C, ALOX15, CDC25B, FLT3, KDR, MMP9, PDE5A, PTGS2, PTPN1, SRC, XDH |
3.21277 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA1, ADORA3, ADRA2A, ADRA2C, AURKB, CDC25B, CSNK2A1, CYP1B1, DHFR, FABP4, FLT3, GSK3B, IGF1R, MET, MMP9, NR1H4, PDE5A, PIM1, PPARA, PTGS2, PTPN1, SRC, TNKS, XDH |
3.14394 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, ADRA2A, ADRA2C, CA2, GSK3B, HCAR2, NR1H4, PTGS2, PTPN1, SRC, THRA |
3.14394 |
[BP] GO:0045742 |
None
|
ADORA1, ADRA2A, ADRA2C, MMP9 |
3.13053 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, FABP3, NR1H4, PPARA |
3.12826 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, CA2, CYP1A1, CYP1A2, FABP4, MAOB, MMP9, PTGS2 |
3.11342 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, CYP19A1, CYP1B1, F10, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
3.09738 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, DHFR, FABP3, KDR, MMP2, NR1H4, PTGS2, SRC |
3.08999 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, AURKB, CSNK2A1, DHFR, FABP4, GSK3B, HCAR2, IGF1R, KDR, MET, MMP9, NR1H4, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, TNKS, TNKS2, XDH |
3.08217 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
3.07537 |
[BP] GO:0045741 |
None
|
ADORA1, ADRA2A, ADRA2C |
3.06396 |
[BP] GO:1901186 |
None
|
ADORA1, ADRA2A, ADRA2C, MMP9 |
3.06396 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA2A, ADRA2C, ALOX15, CDC25B, FLT3, KDR, MMP9, PDE5A, PTGS2, PTPN1, SRC, XDH |
3.05102 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA2A, ADRA2C, ALOX15, CDC25B, FABP4, FLT3, IGF1R, KDR, MMP9, PDE5A, PPARA, PTGS2, PTPN1, SRC, XDH |
3.04015 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FLT3, GSK3B, KDR, MAOB, MMP9, PIM1, PPARA, PTGS2, PTPRS, RORC, SRC, THRA |
2.9692 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADRA2A, ADRA2C, AURKB, CDC25B, FABP4, FLT3, GSK3B, IGF1R, PDE5A, PTPN1, SRC, TNKS |
2.94434 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DAO, FABP3, FABP4, GSK3B, IDO1, MAOB, PDE5A, SRC, XDH |
2.93866 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA2A, ADRA2C, ALOX15, FLT3, IGF1R, KDR, PDE5A, PTPN1, SRC, XDH |
2.92852 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, NR1H4, SRC |
2.92611 |
[BP] GO:0061098 |
None
|
ADORA1, ADRA2A, ADRA2C, PTPN1 |
2.92611 |
[BP] GO:0008050 |
None
|
THRA, THRB |
2.89924 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, CYP19A1, CYP1A2, IDO1, MAOB, XDH |
2.89763 |
[BP] GO:0014070 |
response to organic cyclic compound
|
CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FLT3, MAOB, PTGS2, RORC, SRC |
2.89746 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, FABP3, FABP4, GSK3B, IDO1, MAOB, PDE5A, XDH |
2.89452 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA2A, ADRA2C, ALOX15, CDC25B, FABP4, FLT3, IGF1R, KDR, MMP9, PDE5A, PTGS2, PTPN1, SRC, XDH |
2.87103 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, AURKB, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, FABP4, FLT3, GSK3B, HCAR2, IGF1R, KDR, MAOB, MET, MMP9, NR1H4, PDE5A, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, TNKS, TNKS2, TOP1, XDH |
2.8442 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, AKR1B10, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, DHFR, F10, FABP3, FABP4, FLT3, GSK3B, HCAR2, HSD17B1, IDO1, IGF1R, KDR, MAOB, MET, MMP1, MMP2, MMP9, NR1H4, PDE5A, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SRC, THRA, THRB, TNKS, TNKS2, TOP1, TUBB3, XDH |
2.8442 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
NR1H4, PPARA, RORC, SRC, THRA, THRB |
2.8442 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, CYP19A1, CYP1B1, F10, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
2.83067 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, CYP19A1, CYP1B1, F10, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
2.81869 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.77915 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AXL, CYP1B1, GSK3B, IGF1R, MMP2, MMP9, NR1H4, PTGS2, RORC, SRC |
2.77323 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, ADRA2A, ADRA2C, FLT3, PTPN1, SRC |
2.77006 |
[BP] GO:0045986 |
None
|
ADORA1, ADRA2C, PTGS2 |
2.74614 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX15, ALOX5, PTGS2 |
2.74614 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, DHFR, FABP3, FLT3, GSK3B, IGF1R, MMP2, NR1H4, PPARA, PTGS2, SRC |
2.74614 |
[BP] GO:0051051 |
negative regulation of transport
|
ADORA1, ADRA2A, ADRA2C, GSK3B, MAOB, MMP9, NR1H4, PTGS2, THRA |
2.70127 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.70127 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, CYP1A1, DHFR, PPARA |
2.70127 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.68562 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.67823 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DAO, MAOB |
2.67028 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1 |
2.65916 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.65916 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1 |
2.6422 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.64116 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, FABP4, IDO1, MMP2, NR1H4, PPARA, PTGS2, PTPN1, PTPRS, SRC |
2.63988 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.63606 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA2A, ADRA2C, GSK3B, IGF1R, MET, MMP9, NR1H4, PTGS2, PTPN1, PTPRS, SRC, XDH |
2.62942 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA2A, ADRA2C, GSK3B, IGF1R, MET, MMP9, NR1H4, PTGS2, PTPN1, PTPRS, SRC, XDH |
2.61876 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.6061 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, GSK3B, PPARA, RORC, SRC, TOP1 |
2.60141 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA2A, ADRA2C, HCAR2, PDE5A, PTGS2, THRA, THRB |
2.59136 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA2A, ALOX15, CYP19A1, GSK3B, IGF1R, MET, MMP9, NR1H4, PPARA, PTGS2, PTPN1, PTPRS, SRC, XDH |
2.57057 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, ADRA2A, AXL, CA2, CYP19A1, GSK3B, HCAR2, NR1H4, PTGS2, SRC |
2.56403 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AURKB, CDC25B, CSNK2A1, DHFR, FABP4, FLT3, GSK3B, IGF1R, MMP9, PDE5A, PTGS2, PTPN1, SRC, TNKS, XDH |
2.56071 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.53274 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, DHFR, FABP3, FLT3, GSK3B, IGF1R, MMP2, NR1H4, PPARA, PTGS2, SRC |
2.50489 |
[BP] GO:0065007 |
biological regulation
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, CA1, CA12, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, F10, FABP3, FABP4, FLT3, GSK3B, HCAR2, HSD17B1, IDO1, IGF1R, KDR, MAOB, MET, MMP1, MMP2, MMP9, NR1H4, PDE5A, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SRC, THRA, THRB, TNKS, TNKS2, TOP1, XDH |
2.50108 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, CDC25B, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC, TNKS, TOP1 |
2.49045 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.46937 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.45471 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.45471 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, ADRA2A, ADRA2C, AURKB, CDC25B, FLT3, PDE5A, PTPN1, SRC, TNKS |
2.4502 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, GSK3B, MET, MMP9, PPARA, SRC |
2.44505 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, ADRA2C, AXL, CA2, CYP1B1, HCAR2, IDO1, KDR, MET, MMP9, NR1H4, PDE5A, PIM1, PTGS2, SRC |
2.44196 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC |
2.41819 |
[BP] GO:0050995 |
None
|
ADORA1, ADRA2A, HCAR2 |
2.40249 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, ADORA1, ADRA2A, ADRA2C, AURKB, CDC25B, DHFR, FLT3, GSK3B, MET, MMP9, PDE5A, PTPN1, SRC, TNKS, XDH |
2.40128 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, FLT3, KDR, PPARA, PTPRS, SRC, THRA |
2.38242 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.38134 |
[BP] GO:0050789 |
regulation of biological process
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, CA1, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, F10, FABP3, FABP4, FLT3, GSK3B, HCAR2, IDO1, IGF1R, KDR, MAOB, MET, MMP1, MMP2, MMP9, NR1H4, PDE5A, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SRC, THRA, THRB, TNKS, TNKS2, TOP1, XDH |
2.36313 |
[BP] GO:0006940 |
None
|
ADORA1, ADRA2A, ADRA2C, PTGS2 |
2.36103 |
[BP] GO:0051953 |
None
|
ADORA1, ADRA2A, ADRA2C |
2.36103 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.36103 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, AXL, CA1, CA2, CSNK2A1, CYP1B1, FLT3, GSK3B, HCAR2, IGF1R, KDR, MET, MMP2, MMP9, NR1H4, PDE5A, PIM1, PPARA, PTPN1, RORC, SRC, THRA, THRB, TNKS, TNKS2 |
2.33331 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX15, ALOX5, CYP19A1, CYP1A1, DHFR, IDO1, PTGS2 |
2.32956 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, CDC25B, FLT3, KDR, MMP9, PDE5A, PTGS2, PTPN1, SRC, XDH |
2.31812 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, F10, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
2.31381 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1 |
2.31381 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, AURKB, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DHFR, FABP3, FABP4, FLT3, GSK3B, HCAR2, IGF1R, KDR, MAOB, MET, MMP9, NR1H4, PDE5A, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, TNKS, TNKS2, XDH |
2.30197 |
[BP] GO:0035625 |
None
|
ADRA2A, ADRA2C |
2.29981 |
[BP] GO:0032811 |
None
|
ADRA2A, ADRA2C |
2.29981 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.29981 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.29981 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.29981 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, AURKB, CSNK2A1, DHFR, FABP4, GSK3B, IGF1R, MET, MMP9, NR1H4, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, TNKS, TNKS2, XDH |
2.29929 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, IDO1 |
2.29143 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, CDC25B, CSNK2A1, FLT3, IGF1R, KDR, MMP2, MMP9, PIM1, PTGS2 |
2.28089 |
[BP] GO:1901361 |
None
|
CYP19A1, CYP1A1, CYP1A2, DAO, IDO1, MAOB, PDE5A, XDH |
2.2575 |
[BP] GO:0006091 |
generation of precursor metabolites and energy
|
AKR1B1, CYP19A1, CYP1A2, GSK3B, IDO1, MAOB, XDH |
2.2363 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.2363 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, F10, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
2.2363 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, CDC25B, CSNK2A1, FLT3, GSK3B, KDR, MMP9, PDE5A, PTGS2, PTPN1, SRC, XDH |
2.23626 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, NR1H4, SRC |
2.23422 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, ADRA2A, MAOB, MMP9, PTGS2 |
2.23422 |
[BP] GO:0050730 |
None
|
ADORA1, ADRA2A, ADRA2C, FLT3, PTPN1, SRC |
2.22806 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, ADRA2A, FLT3, IGF1R, PDE5A, PTPN1, SRC |
2.21393 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.19794 |
[BP] GO:0032845 |
None
|
ADORA1, ADRA2A, SRC, TNKS, TNKS2 |
2.19794 |
[BP] GO:0061097 |
None
|
ADORA1, ADRA2A, ADRA2C, PTPN1 |
2.19744 |
[BP] GO:0051098 |
regulation of binding
|
AURKB, GSK3B, MET, MMP9, PPARA, SRC, TNKS |
2.19707 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DHFR, GSK3B, IDO1, MMP2, MMP9, NR1H4, PPARA, PTGS2, PTPN1, SRC, THRA |
2.17095 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, F10, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
2.17095 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PTGS2 |
2.15908 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, FABP3, GSK3B, IGF1R, PPARA, PTGS2, SRC |
2.15688 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, GSK3B, KDR, MET, MMP9, SRC, TNKS, TNKS2 |
2.13639 |
[BP] GO:0035624 |
None
|
ADRA2A, ADRA2C |
2.12531 |
[BP] GO:0060509 |
None
|
THRA, THRB |
2.12531 |
[BP] GO:0014060 |
None
|
ADRA2A, ADRA2C |
2.12531 |
[BP] GO:0032204 |
None
|
AURKB, SRC, TNKS, TNKS2 |
2.12524 |
[BP] GO:0007176 |
None
|
ADORA1, ADRA2A, ADRA2C |
2.1252 |
[BP] GO:0070542 |
None
|
FABP3, NR1H4, PTGS2, SRC |
2.08738 |
[BP] GO:0045833 |
None
|
ADORA1, ADRA2A, HCAR2, NR1H4 |
2.08738 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, MAOB |
2.08539 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, F10, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
2.08434 |
[BP] GO:0051100 |
negative regulation of binding
|
AURKB, GSK3B, MET, PPARA, TNKS |
2.07912 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA2A, ADRA2C, PTGS2, SRC |
2.07912 |
[BP] GO:0051223 |
None
|
ACHE, ADRA2A, ADRA2C, GSK3B, HCAR2, NR1H4, PTGS2, PTPN1, SRC, THRA |
2.07792 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, FABP4, IDO1, KDR, MET, NR1H4, PPARA, PTGS2, PTPRS |
2.07499 |
[BP] GO:2000106 |
regulation of leukocyte apoptotic process
|
AURKB, AXL, HCAR2, IDO1 |
2.06199 |
[BP] GO:0044070 |
regulation of anion transport
|
ABCB1, ADORA1, CA2, CA7 |
2.06199 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, ADRA2A, ADRA2C, CDC25B, FABP4, FLT3, IGF1R, PDE5A, PTPN1, SRC |
2.0558 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, AURKB, CDC25B, CSNK2A1, CYP1A2, CYP1B1, DHFR, FABP4, FLT3, GSK3B, IGF1R, KDR, MET, MMP9, NR1H4, PDE5A, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, TNKS, TNKS2, TOP1, XDH |
2.03153 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
NR1H4, PPARA, RORC, THRA, THRB |
2.02875 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7 |
2.02612 |
[BP] GO:2000273 |
None
|
ADORA1, ADRA2A, ADRA2C |
2.02612 |
[BP] GO:0006937 |
None
|
ADORA1, ADRA2A, ADRA2C, PDE5A, PTGS2 |
2.02233 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SRC |
2.01489 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX15, CYP19A1, DAO, DHFR |
2.01437 |
[BP] GO:0042058 |
None
|
ADORA1, ADRA2A, ADRA2C, MMP9 |
2.00049 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRA2C, AKR1B1, AKR1B10, ALOX15, ALOX5, AURKB, CA1, CA2, CA4, CA7, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, DHFR, F10, FABP3, FABP4, FLT3, GSK3B, HSD17B1, IDO1, KDR, MAOB, MMP2, MMP9, PDE5A, PIM1, PTGS2, PTPN1, PTPRS, SRC, THRA, TNKS, TNKS2, TOP1, XDH |
2.0676 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
1.9997 |
[CC] GO:0099055 |
None
|
ADORA1, PTPRS |
1.73816 |
[CC] GO:0099699 |
None
|
ADORA1, PTPRS |
1.73816 |
[CC] GO:0099240 |
None
|
ADORA1, PTPRS |
1.73816 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, DHFR, F10, FABP3, FABP4, FLT3, GSK3B, HSD17B1, IDO1, IGF1R, KDR, MAOB, MET, MMP1, MMP2, MMP9, NR1H4, PDE5A, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SRC, THRA, THRB, TNKS, TNKS2, TOP1, TUBB3, XDH |
11.5297 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, DHFR, F10, FLT3, GSK3B, HSD17B1, IDO1, IGF1R, KDR, MAOB, MET, MMP1, MMP2, MMP9, PDE5A, PIM1, PTGS2, PTPN1, PTPRS, SRC, TNKS, TNKS2, TOP1, TUBB3, XDH |
10.4637 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, MMP1, MMP2, MMP9, NR1H4, PIM1, PPARA, PTPN1, RORC, THRA, THRB, TNKS, XDH |
9.99519 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
8.17656 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, DHFR, HSD17B1, IDO1, MAOB, PTGS2, XDH |
6.31437 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, MMP1, MMP2, MMP9, NR1H4, PPARA, PTPN1, RORC, THRA, THRB, TNKS |
5.17264 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.09068 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, DHFR, HSD17B1, IDO1, MAOB, PTGS2, SRC, XDH |
5.06063 |
[MF] GO:0043168 |
anion binding
|
ABCB1, ALOX15, AURKB, AXL, CSNK2A1, DAO, DHFR, F10, FABP3, FABP4, FLT3, GSK3B, HSD17B1, IGF1R, KDR, MAOB, MET, NR1H4, PDE5A, PIM1, PTPRS, SRC, TOP1, TUBB3, XDH |
4.49039 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
4.39396 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, PTGS2, SRC |
4.36096 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F10, IDO1, MMP1, MMP2, MMP9, NR1H4, PDE5A, PIM1, PPARA, PTGS2, PTPN1, RORC, THRA, THRB, TNKS, TNKS2, XDH |
4.28243 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, PTGS2, SRC |
4.21078 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, ADORA1, AURKB, AXL, CSNK2A1, DAO, DHFR, FABP3, FABP4, FLT3, GSK3B, HSD17B1, IGF1R, KDR, MAOB, MET, NR1H4, PDE5A, PIM1, SRC, TOP1, TUBB3, XDH |
4.19226 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F10, IDO1, MMP1, MMP2, MMP9, NR1H4, PDE5A, PIM1, PPARA, PTGS2, PTPN1, RORC, THRA, THRB, TNKS, TNKS2, XDH |
4.00258 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, PPARA, SRC, TOP1 |
3.98963 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
NR1H4, PPARA, RORC, THRA, THRB |
3.98963 |
[MF] GO:0004879 |
nuclear receptor activity
|
NR1H4, PPARA, RORC, THRA, THRB |
3.98963 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
3.89196 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.81839 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, IDO1, MAOB, XDH |
3.71546 |
[MF] GO:0004887 |
None
|
NR1H4, THRA, THRB |
3.70783 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
NR1H4, PPARA, RORC, THRA, THRB |
3.70783 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.6615 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX15, ALOX5, IDO1, PTGS2 |
3.6615 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.62025 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX15, ALOX5, IDO1, PTGS2 |
3.60519 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC, TOP1 |
3.23748 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.18237 |
[MF] GO:0042562 |
hormone binding
|
ACHE, HSD17B1, IGF1R, THRA, THRB |
3.06396 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, CSNK2A1, FLT3, IGF1R, KDR, MMP9, PIM1, PPARA, PTPN1, SRC, THRA |
3.05748 |
[MF] GO:0000166 |
nucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, DAO, DHFR, FLT3, GSK3B, HSD17B1, IGF1R, KDR, MAOB, MET, PDE5A, PIM1, SRC, TOP1, TUBB3, XDH |
3.00325 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCB1, AURKB, AXL, CSNK2A1, DAO, DHFR, FLT3, GSK3B, HSD17B1, IGF1R, KDR, MAOB, MET, PDE5A, PIM1, SRC, TOP1, TUBB3, XDH |
3.00321 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, FLT3, HCAR2, IGF1R, KDR, MET, NR1H4, PPARA, RORC, THRA, THRB |
2.89099 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.86578 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.67891 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
2.65071 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC, TOP1 |
2.64808 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, FLT3, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, THRA |
2.61876 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.53274 |
[MF] GO:0004938 |
None
|
ADRA2A, ADRA2C |
2.53274 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ABCB1, ADORA1, ADRA2A, ADRA2C, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, DHFR, FLT3, GSK3B, HSD17B1, IDO1, IGF1R, KDR, MAOB, MET, NR1H4, PDE5A, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, TOP1, TUBB3, XDH |
2.52428 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, FLT3, HCAR2, IGF1R, KDR, MET, NR1H4, PPARA, RORC, THRA, THRB |
2.39472 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC, TOP1 |
2.36649 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.29981 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, CBR1, HSD17B1, XDH |
2.29143 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, FLT3, HCAR2, IGF1R, KDR, MET, NR1H4, PPARA, RORC, THRA, THRB |
2.28089 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS2 |
2.07912 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.05844 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, FLT3, HCAR2, IGF1R, KDR, MET, NR1H4, PPARA, RORC, THRA, THRB |
2.02612 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDC25B, CSNK2A1, F10, FLT3, GSK3B, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PTPN1, PTPRS, SRC, TOP1 |
2.01437 |